Navigation Links
Peptide derived from cow's milk kills human stomach cancer cells in culture
Date:11/7/2013

Philadelphia, PA, November 7, 2013 New research from a team of researchers in Taiwan indicates that a peptide fragment derived from cow's milk, known as lactoferricin B25 (LFcinB25), exhibited potent anticancer capability against human stomach cancer cell cultures. The findings, published in the Journal of Dairy Science, provide support for future use of LFcinB25 as a potential therapeutic agent for gastric cancer.

"Gastric cancer is one of the most common causes of cancer-related mortality worldwide, especially in Asian countries," says Wei-Jung Chen, PhD, of the Department of Biotechnology and Animal Science of National Ilan University, Taiwan Republic of China. "In general, the main curative therapies for gastric cancer are surgery and chemotherapy, which are generally only successful if the cancer is diagnosed at an early stage. Novel treatment strategies to improve prognosis are urgently needed."

Investigators evaluated the effects of three peptide fragments derived from lactoferricin B, a peptide in milk that has antimicrobial properties. Only one of the fragments, LFcinB25 reduced the survival of human AGS (Gastric Adenocarcinoma) cells in a dose-dependent and time-dependent manner.

Under a microscope the investigators could see that after an hour of exposure to the gastric cancer cells, LFcinB25 migrated to the cell membrane of the AGS cells, and within 24 hours the cancer cells had shrunken in size and lost their ability to adhere to surfaces. In the early stages of exposure, LFcinB25 reduced cell viability through both apoptosis (programmed cell death) and autophagy (degradation and recycling of obsolete or damaged cell parts). At later stages, apoptosis appeared to dominate, possibly through caspase-dependent mechanisms, and autophagy waned.

"This is the first report describing interplay between apoptosis and autophagy in LFcinB-induced cell death of cancer cells," says Dr. Chen.

The research also suggested a target, Beclin-1, which may enhance LFcinB25's cytotoxic action. Beclin-1 is a protein in humans that plays a central role in autophagy, tumor growth, and degeneration of neurons. In this study, the investigators found that cleaved beclin-1 increased in a time-dependent manner after LFcinB25-exposure, suggesting to the authors a new approach in drug development that may boost the anticancer effects of LFcinB25.

"Optimization of LFcinB using various strategies to enhance further selectivity is expected to yield novel anticancer drugs with chemotherapeutic potential for the treatment of gastric cancer," concludes Dr. Chen.


'/>"/>

Contact: Eileen Leahy
jdsmedia@elsevier.com
732-238-3628
Elsevier Health Sciences
Source:Eurekalert

Related medicine news :

1. Combination peptide therapies might offer more effective, less toxic cancer treatment
2. Synthetic corkscrew peptide kills antibiotic-resistant Gram-negative bacteria
3. Is this peptide a key to happiness?
4. Global Peptide Therapeutics Market - New Market Research Report Published by Transparency Market Research
5. Collagen is a Key Anti-Aging Ingredient and is Featured in the New Collagen Peptide Serum at Sublime Beauty®; Introductory Offer on Now
6. Last Chance for the Sublime Beauty® Serums at 30-Percent Off; Quality Anti-Aging Products Include Retinol Serum, Collagen Peptide Serum and Luxurious Facial Oil
7. Consuming soy peptide may reduce colon cancer metastasis
8. New England Peptide, Inc. and Cambridge Isotope Laboratories, Inc. Announce Quantitative Proteomics Manufacturing Collaboration
9. Zion Health's Mineral Beauty Balm Contains Natural SunScreen SPF 30 & Anti-Aging Fruit Peptides- Now Available At Green Acres Health Food Store in Wichita, Kansas.
10. Researchers target HER1 receptor for peptide cancer vaccine, therapeutic agents
11. Lotus Moon Launches Skin Boost, a Peptide Serum with 78 Percent Organic Content
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/21/2017)... , ... July 21, 2017 , ... ... at 10 years, researchers from the Multicenter Orthopaedics Outcome Network (MOON) demonstrated that ... a decade after surgery, though activity levels decline over time. The study, presented ...
(Date:7/20/2017)... ... July 20, 2017 , ... Acute ... marrow cancer that progresses rapidly without treatment. Newly diagnosed patients face intense chemotherapy ... of reoccurrence and relapse. With such a challenging diagnosis that requires immediate ...
(Date:7/20/2017)... ... ... Team Type 1 Foundation, a nonprofit organization pursuing a global mission of ... up with a Microsoft Corp. employee-led hackathon team for the 2017 Microsoft One Week ... Type 1’s mission overlaps seamlessly with Microsoft’s mission to empower every person and every ...
(Date:7/20/2017)... ... ... The Dermatology Clinic announced today the addition of Dr. Scott W. Dunbar, ... graduating summa cum laude. He attended Emory University School of Medicine in Atlanta where ... Dunbar moved to New York to complete an AGCME-accredited Mohs surgery fellowship to become ...
(Date:7/20/2017)... Alexandria, VA (PRWEB) , ... July 20, 2017 , ... ... annual Social Security cost – of - living - adjustment (COLA) is a bad ... The proposed “chained” consumer price index (CPI) would grow even more slowly than ...
Breaking Medicine News(10 mins):
(Date:7/13/2017)... July 13, 2017 RK Logistics Group, Inc. was ... certification for its Fremont, CA headquarters ... the Tri-Valley and San Jose for ... of Fremont , with its Fremont Innovation District, is ... such a powerful resource to the hundreds of biotech, pharma ...
(Date:7/11/2017)... , July 11, 2017 Zymo Research Corp., also known ... that can quantify biological aging in a precise manner using the myDNAge ... Steve Horvath , a professor of human genetics and biostatistics at the ... School of Public Health , Zymo Research,s proprietary DNAge ™ technology ... ...
(Date:7/11/2017)...  Dr. Echenberg, founder of Echenberg Institute, is announcing a new safe ... from painful intercourse and other painful pelvic pain conditions such as pelvic ... ... ... Florida -based start-up company, VuVatech LLC, fills a void in the ...
Breaking Medicine Technology: